112 related articles for article (PubMed ID: 15359994)
41. A 15-year analysis of early and late autologous hematopoietic stem cell transplant in relapsed, aggressive, transformed, and nontransformed follicular lymphoma.
Sabloff M; Atkins HL; Bence-Bruckler I; Bredeson C; Fergusson D; Genest P; Hopkins H; Hutton B; Mcdiarmid S; Huebsch LB
Biol Blood Marrow Transplant; 2007 Aug; 13(8):956-64. PubMed ID: 17640600
[TBL] [Abstract][Full Text] [Related]
42. Identification of prognostic groups in follicular lymphoma. The Scotland and Newcastle Lymphoma Group Therapy Working Party.
Cameron DA; Leonard RC; Mao JH; Prescott RJ
Leuk Lymphoma; 1993 May; 10(1-2):89-99. PubMed ID: 8374528
[TBL] [Abstract][Full Text] [Related]
43. Rituximab for the first-line treatment of stage III-IV follicular lymphoma (review of Technology Appraisal No. 110): a systematic review and economic evaluation.
Papaioannou D; Rafia R; Rathbone J; Stevenson M; Buckley Woods H; Stevens J
Health Technol Assess; 2012; 16(37):1-253, iii-iv. PubMed ID: 23021127
[TBL] [Abstract][Full Text] [Related]
44. Primary follicular lymphoma of the gastrointestinal tract.
Misdraji J; Harris NL; Hasserjian RP; Lauwers GY; Ferry JA
Am J Surg Pathol; 2011 Sep; 35(9):1255-63. PubMed ID: 21836483
[TBL] [Abstract][Full Text] [Related]
45. Individualized management of follicular lymphoma.
Bai B; Huang HQ
Chin Clin Oncol; 2015 Mar; 4(1):7. PubMed ID: 25841714
[TBL] [Abstract][Full Text] [Related]
46. Clinical characteristics and early treatment outcomes of follicular lymphoma in young adults.
Gangatharan SA; Maganti M; Kuruvilla JG; Kukreti V; Tiedemann RE; Gospodarowicz MK; Hodgson DC; Sun A; Tsang RW; Pintilie M; Crump M
Br J Haematol; 2015 Aug; 170(3):384-90. PubMed ID: 25904266
[TBL] [Abstract][Full Text] [Related]
47. Long-term survival after histologic transformation of low-grade follicular lymphoma.
Yuen AR; Kamel OW; Halpern J; Horning SJ
J Clin Oncol; 1995 Jul; 13(7):1726-33. PubMed ID: 7602362
[TBL] [Abstract][Full Text] [Related]
48. High dose cyclophosphamide plus recombinant human granulocyte-colony stimulating factor (rhG-CSF) in the treatment of follicular, low grade non-Hodgkin's lymphoma: CALGB 9150.
Lichtman SM; Petroni G; Schilsky RL; Johnson JL; Perri RT; Niedzwiecki D; Sklar J; Barcos M; Peterson BA
Leuk Lymphoma; 2001; 42(6):1255-64. PubMed ID: 11911406
[TBL] [Abstract][Full Text] [Related]
49. A pilot study on the use of the ProMACE-CytaBOM regimen as a first-line treatment of advanced follicular non-Hodgkin's lymphoma. Gruppo Italiano per lo Studio dei Linfomi.
Baldini L; Guffanti A; Gobbi P; Colombi M; Federico M; Avanzini P; Cavanna L; Pieresca C; Silingardi V; Maiolo AT
Cancer; 1997 Mar; 79(6):1234-40. PubMed ID: 9070503
[TBL] [Abstract][Full Text] [Related]
50. Tumor sclerosis but not cell proliferation or malignancy grade is a prognostic marker in advanced-stage follicular lymphoma: the German Low Grade Lymphoma Study Group.
Klapper W; Hoster E; Rölver L; Schrader C; Janssen D; Tiemann M; Bernd HW; Determann O; Hansmann ML; Möller P; Feller A; Stein H; Wacker HH; Dreyling M; Unterhalt M; Hiddemann W; Ott G;
J Clin Oncol; 2007 Aug; 25(22):3330-6. PubMed ID: 17664481
[TBL] [Abstract][Full Text] [Related]
51. A third generation regimen VACOP-B with or without adjuvant radiotherapy for aggressive localized non-Hodgkin's lymphoma: report from the Italian Non-Hodgkin's Lymphoma Co-operative Study Group.
Santini G; De Souza C; Aversa S; Patti C; Tedeschi L; Candela M; Olivieri A; Chisesi T; Rubagotti A; Centurioni R; Nardi V; Congiu M; Gennaro M; Truini M;
Braz J Med Biol Res; 2004 May; 37(5):719-28. PubMed ID: 15107935
[TBL] [Abstract][Full Text] [Related]
52. A numerical prognostic index for clinical use in identification of poor-risk patients with Hodgkin's disease at diagnosis. The Scotland and Newcastle Lymphoma Group (SNLG) Therapy Working Party.
Proctor SJ; Taylor P; Mackie MJ; Donnan P; Boys R; Lennard A; Prescott RJ
Leuk Lymphoma; 1992; 7 Suppl():17-20. PubMed ID: 1493453
[TBL] [Abstract][Full Text] [Related]
53. [Prognostic factors of primary non-Hodgkin's lymphoma of the nasal cavity--a report of 129 cases].
Yao B; Li YX; Fang H; Jin J; Liu XF; Yu ZH
Ai Zheng; 2006 Apr; 25(4):465-70. PubMed ID: 16613682
[TBL] [Abstract][Full Text] [Related]
54. Anthracycline-based chemotherapy of primary non-Hodgkin's lymphoma of the testis: the hellenic cooperative oncology group experience.
Pectasides D; Economopoulos T; Kouvatseas G; Antoniou A; Zoumbos Z; Aravantinos G; Tsatalas C; Halikia A; Nikolaides C; Kiamouris C; Pappa E; Pavlidis N; Skarlos D; Fountzilas G; Dimopoulos MA
Oncology; 2000 May; 58(4):286-92. PubMed ID: 10838493
[TBL] [Abstract][Full Text] [Related]
55. [A clinical observation of fludarabine-containing regimens in the treatment of low grade non-Hodgkin's lymphoma].
Lü SQ; Yang JM; Song XM; Chen L; Zhang WP; Ni X; Xu XQ; Wang JM
Zhonghua Zhong Liu Za Zhi; 2007 Sep; 29(9):710-2. PubMed ID: 18246806
[TBL] [Abstract][Full Text] [Related]
56. [Clinical Features, Treatment and Prognostic Factors of 94 Patients with Follicular Lymphoma].
DU XY; Hu K; Zhao W; Yang P; Wan W; Jing HM; Ke XY
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2018 Jun; 26(3):756-764. PubMed ID: 29950216
[TBL] [Abstract][Full Text] [Related]
57. Autologous hematopoietic stem cell transplantation for relapsed follicular lymphoma: safety profile and clinical outcome in a single-center experience.
Helbig G; Krawczyk-Kulis M; Kopinska A; Liwoch R; Kyrcz-Krzemien S
Med Oncol; 2014 Dec; 31(12):310. PubMed ID: 25373321
[TBL] [Abstract][Full Text] [Related]
58. Outcome of advanced stage low grade follicular lymphomas in a population-based retrospective cohort.
Wood LA; Coupland RW; North SA; Palmer MC
Cancer; 1999 Mar; 85(6):1361-8. PubMed ID: 10189143
[TBL] [Abstract][Full Text] [Related]
59. Place of low-dose total body irradiation in the treatment of localized follicular non-Hodgkin's lymphoma: results of a pilot study.
Richaud PM; Soubeyran P; Eghbali H; Chacon B; Marit G; Broustet A; Hoerni B
Int J Radiat Oncol Biol Phys; 1998 Jan; 40(2):387-90. PubMed ID: 9457825
[TBL] [Abstract][Full Text] [Related]
60. Impact of the Follicular Lymphoma International Prognostic Index risk categorization on survival of patients with follicular lymphoma in Pakistani population: a single centre experience.
Athar S; Siddiqui N; Hameed A; Mahmood MT; Khan MZ
J Pak Med Assoc; 2014 May; 64(5):563-6. PubMed ID: 25272545
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
